4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-22-000116
President and CEO gave up 5,343 shares (to pay taxes)
- President and CEO acquired 15,450 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Culley Brian M · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-12-31 | Exercise or conversion : show line 1 in the form | +15,450 | 81,373 | D | ||
| 2021-12-31 | Shares withheld for taxes : show line 2 in the form | −5,343 | $2.45 | $13,090 | 76,030 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-12-31 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −15,450 | 30,900 | D |
Loading xslF345X03/ownership.xml…